Skip to main content
Journal cover image

Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.

Publication ,  Journal Article
Sinning, J-M; Wollert, KC; Sedaghat, A; Widera, C; Radermacher, M-C; Descoups, C; Hammerstingl, C; Weber, M; Stundl, A; Ghanem, A; Widder, J ...
Published in: Am Heart J
October 2015

BACKGROUND: Up to 50% of the patients still die or have to be rehospitalized during the first year after transcatheter aortic valve replacement (TAVR). This emphasizes the need for more strategic patient selection. The aim of this prospective observational cohort study was to compare the prognostic value of risk scores and circulating biomarkers to predict all-cause mortality and rehospitalization in patients undergoing TAVR. METHODS: We calculated the hazard ratios and C-statistics (area under the curve [AUC]) of 4 risk scores (logistic European System for Cardiac Operative Risk Evaluation [EuroSCORE], EuroSCORE II, Society of Thoracic Surgeons predicted risk of mortality, and German aortic valve score) and 5 biomarkers of inflammation and/or myocardial dysfunction (high-sensitivity C-reactive protein, growth differentiation factor (GDF)-15, interleukin-6, interleukin-8, and N-terminal pro-B-type natriuretic peptide) for the risk of death (n = 80) and the combination of death or rehospitalization (n = 132) during the first year after TAVR in 310 consecutive TAVR patients. RESULTS: The EuroSCORE II and GDF-15 had the strongest predictive value for 1-year mortality (EuroSCORE II, AUC 0.711; GDF-15, AUC 0.686) and for the composite end point (EuroSCORE II, AUC 0.690; GDF-15, AUC 0.682). When added to the logistic EuroSCORE and EuroSCORE II, GDF-15 enhanced the prognostic performance of the score and enabled substantial reclassification of patients. Combinations of increasing tertiles of the logistic EuroSCORE or EuroSCORE II and GDF-15 allowed the stratification of the patients into subgroups with mortality rates ranging from 4.0% to 49.1% and death/rehospitalization rates ranging from 15.3% to 68.4%. CONCLUSIONS: Our study identified GDF-15 in addition to the logistic EuroSCORE and the EuroSCORE II as the most promising predictors of a poor outcome after TAVR.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2015

Volume

170

Issue

4

Start / End Page

821 / 829

Location

United States

Related Subject Headings

  • Transcatheter Aortic Valve Replacement
  • Time Factors
  • Survival Rate
  • Risk Factors
  • Risk Assessment
  • Retrospective Studies
  • Postoperative Complications
  • Patient Readmission
  • Male
  • Incidence
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sinning, J.-M., Wollert, K. C., Sedaghat, A., Widera, C., Radermacher, M.-C., Descoups, C., … Kempf, T. (2015). Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. Am Heart J, 170(4), 821–829. https://doi.org/10.1016/j.ahj.2015.07.003
Sinning, Jan-Malte, Kai C. Wollert, Alexander Sedaghat, Christian Widera, Marie-Caroline Radermacher, Claire Descoups, Christoph Hammerstingl, et al. “Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.Am Heart J 170, no. 4 (October 2015): 821–29. https://doi.org/10.1016/j.ahj.2015.07.003.
Sinning J-M, Wollert KC, Sedaghat A, Widera C, Radermacher M-C, Descoups C, et al. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. Am Heart J. 2015 Oct;170(4):821–9.
Sinning, Jan-Malte, et al. “Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.Am Heart J, vol. 170, no. 4, Oct. 2015, pp. 821–29. Pubmed, doi:10.1016/j.ahj.2015.07.003.
Sinning J-M, Wollert KC, Sedaghat A, Widera C, Radermacher M-C, Descoups C, Hammerstingl C, Weber M, Stundl A, Ghanem A, Widder J, Vasa-Nicotera M, Mellert F, Schiller W, Bauersachs J, Zur B, Holdenrieder S, Welz A, Grube E, Pencina MJ, Nickenig G, Werner N, Kempf T. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement. Am Heart J. 2015 Oct;170(4):821–829.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

October 2015

Volume

170

Issue

4

Start / End Page

821 / 829

Location

United States

Related Subject Headings

  • Transcatheter Aortic Valve Replacement
  • Time Factors
  • Survival Rate
  • Risk Factors
  • Risk Assessment
  • Retrospective Studies
  • Postoperative Complications
  • Patient Readmission
  • Male
  • Incidence